NCT07188428View on ClinicalTrials.gov

Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment

CompletedOBSERVATIONAL
Enrollment

2,298

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

December 2, 2024

Study Completion Date

December 2, 2024

Conditions
Leukemia, Chronic Myeloid
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY